Replies to post #106715 on OWC Pharmaceutical Research Corp (OWCP)

[Lonewolf1]

Gary,
You make very good points and have obviously done your DD.

Unfortunately, the company has not communicated sufficient progress in any of these areas (partnerships, institutional investment, product development, distribution) to stem what can only be called a horrendous slide in PPS.

Sadly, we are returning to a valuation suited to an early development-stage company with little likelihood of showing any profits near-term. What is that price? Who knows, but it could go much lower than the current valuation. The $3.15 OWCP ran to is virtually irrelevant now, since it attained this price on sheer hype.

Again, I hope I'm wrong here. I hope OWCP is able to hold .31 resistance and begins a slow climb back toward $1. But I just don't expect the company to help with this, since they have failed to help since $3.15 last February. GLTA